Variant report
Variant | nsv519845 |
---|---|
Chromosome Location | chr4:92880124-92883522 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1602073 | chr4:92880124-92880125 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs551942983 | chr4:92880130-92880131 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565474944 | chr4:92880148-92880149 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150471085 | chr4:92880152-92880153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370925977 | chr4:92880167-92880168 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371283758 | chr4:92880194-92880195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527868704 | chr4:92880215-92880216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547828086 | chr4:92880220-92880221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567624671 | chr4:92880238-92880239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182379100 | chr4:92880288-92880289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57187016 | chr4:92880296-92880297 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187869430 | chr4:92880328-92880329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537677323 | chr4:92880378-92880379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115992413 | chr4:92880421-92880422 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577884539 | chr4:92880422-92880423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533805345 | chr4:92880475-92880476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553362481 | chr4:92880487-92880488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573255816 | chr4:92880491-92880492 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542214201 | chr4:92880543-92880544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2904396 | chr4:92880544-92880545 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs576072212 | chr4:92880645-92880646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567757234 | chr4:92880701-92880702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545300962 | chr4:92880722-92880723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192506224 | chr4:92880737-92880738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528000710 | chr4:92880746-92880747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs28834203 | chr4:92880764-92880765 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs561563091 | chr4:92880775-92880776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78984974 | chr4:92880838-92880839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530155346 | chr4:92880943-92880944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370620013 | chr4:92880966-92880967 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs550181488 | chr4:92880982-92880983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570077127 | chr4:92881026-92881027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117339205 | chr4:92881050-92881051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551304615 | chr4:92881054-92881055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184664838 | chr4:92881064-92881065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142529183 | chr4:92881075-92881076 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553700043 | chr4:92881102-92881103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573589410 | chr4:92881104-92881105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575427274 | chr4:92881105-92881106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs11947187 | chr4:92881118-92881119 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs62311143 | chr4:92881133-92881134 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs189457931 | chr4:92881146-92881147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544817580 | chr4:92881191-92881192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545046377 | chr4:92881195-92881196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558886749 | chr4:92881198-92881199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572915792 | chr4:92881240-92881241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372146065 | chr4:92881256-92881257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568293945 | chr4:92881289-92881290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116459928 | chr4:92881351-92881352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191996699 | chr4:92881357-92881358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92879000-92880200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr4:92879000-92880600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr4:92879000-92880800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr4:92879000-92881000 | Enhancers | Brain Germinal Matrix | brain |
5 | chr4:92879600-92880200 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr4:92879600-92880200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr4:92879600-92884800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr4:92879800-92880200 | Weak transcription | Fetal Brain Male | brain |
9 | chr4:92880000-92880200 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr4:92880200-92880400 | Enhancers | Fetal Brain Male | brain |
11 | chr4:92880200-92884600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr4:92880400-92884200 | Weak transcription | Fetal Brain Male | brain |
13 | chr4:92882800-92883200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
14 | chr4:92882800-92883400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
15 | chr4:92883000-92883200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr4:92883000-92883400 | Enhancers | Ovary | ovary |
17 | chr4:92883000-92883800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr4:92883200-92884200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |